期刊文献+

肠型胃腺癌及不典型增生组织中血管活性肠肽mRNA表达的研究 被引量:14

The expression of vasoactive intestinal peptide mRNA in gastric adenocarcinoma of intestinal type and dysplasia
原文传递
导出
摘要 目的 血管活性肠肽 (VIP)与肿瘤关系密切 ,VIP可促进和 /或抑制一些肿瘤生长 ,而且一些肿瘤细胞有VIP的自分泌调节作用。VIP对胃癌生长的影响 ,胃癌细胞是否分泌VIP及存在VIP自分泌调节作用尚有争议。研究肠型胃腺癌及不典型增生组织中VIPmRNA的表达情况 ,试图探讨VIP在胃腺癌发生发展中的作用。方法 通过RT PCR方法 ,检测 1 5例正常胃窦黏膜、1 6例不典型增生胃黏膜及 2 0例肠型胃腺癌组织中VIPmRNA的表达量 ,通过与恒定表达的β actin(内参照 )mRNA表达量比较 ,计算出VIPmRNA与 β actinmRNA表达量的积分光密度比值 (V/B) ,以V/B值反映各组织中VIPmRNA表达量的高低。结果 肠型胃腺癌组织中V/B值明显高于不典型增生胃黏膜及正常胃窦黏膜 ,其V/B值分别为 :1 .452 2± 0 .32 82 ,0 .962 3± 0 .2 2 5 0 ,0 .951 3± 0 .2 66 9,差异有非常显著性 (P<0 .0 1 )。正常胃窦黏膜与不典型增生胃黏膜中 ,V/B值的差异无显著性 (P >0 .0 5)。结论 肠型胃腺癌组织VIPmRNA表达量明显高于不典型增生胃黏膜 ;VIP可能在肠型胃腺癌的发生发展中起重要的作用。 Objective It has been known that vasoactive intestinal peptide (VIP) is closely related with the development of tumors; in particular it enhances and/or inhibits the growth of some tumors. There is a VIP autocrine regulation in some tumors, but the effect of VIP on the growth of gastric cancer has been argued. Whether gastric cancer cells secrete VIP or VIP autocrine regulation exists in the gastric cancer cells has not yet been reported. The purpose of the study was to observe the expression of VIP mRNA in gastric mucosa of patients with dysplasia and gastric adenocarcinoma tissues of intestinal type, and to evaluate the role of VIP in the pathogenesis of gastric adenocarcinoma. Methods Using RT PCR method, we detected the VIP mRNA expression in antral mucosa of 15 healthy controls, gastric mucosa of 16 patients with dysplasia and 20 patients with gastric adenocarcinoma of intestinal type. The ratio(V/B) of integrated optical density of VIP mRNA to that of β actin mRNA was calculated. The relative expression of VIP mRNA was represented by V/B. Results The V/B of gastric adenocarcinoma tissues of intestinal type was greater than that of gastric mucosa of patients with dysplasia and the antral mucosa of healthy controls( P <0.01), The former values of V/B were 1.452 2± 0.328 2,0.962 3±0.225 0, 0.951 3±0.266 9 respectively. There was no significant difference in V/B between healthy controls and patients with dysplasia( P >0.05). Conclusions The expression of VIP mRNA in the gastric adenocarcinoma of intestinal type was higher than that in dysplasia. VIP may play an important role in the pathogenesis and progress of gastric adenocarcinoma of intestinal type.
出处 《中华消化杂志》 CAS CSCD 北大核心 2002年第11期674-677,共4页 Chinese Journal of Digestion
关键词 肠型胃肠癌 不典型增生 血管活性肠肽 MRNA Gastric adenocarcinoma of intestinal type Atypic hyperplasia Vasoactive intestinal peptide
  • 相关文献

参考文献2

二级参考文献9

  • 1王鲁平,梁延杰,史景泉.神经内分泌细胞在胃癌及癌旁粘膜中的表达及其意义[J].国外医学(内分泌学分册),1993,13(2):72-75. 被引量:1
  • 2Xu CT, Pan BR, Wang YM. Study on the peptides of serum and gastric juice in patients with gastric cancer. Chung-Hua-I-Hsueh-Tsa-Chih-Taipei,1993;52(1):32.
  • 3Akishi O,Masayoshi M,Tomomi O et al.Endocrine differentiation of gastric adenocarcinoma.Cancer,1988;62:1096.
  • 4Kurki P,Ogata X,Tan EM.Monoclonal antibodies to proliferation cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry J Immunol Methods, 1988;109:49.
  • 5Virgolini I, Raderer M, Krutaran A et al. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.N Engl J Med,1994;331(17):1116.
  • 6Iishi H, Tatsuta M, Baba M et al. Enhancement by vasoactive intestinal peptide of gastric eareinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats,Int J Cancer, 1992;50(4):649.
  • 7Yu D, Seitz PK, Selvanayagam P et al. Effects of vasoactive intestinal peptide on adenosine 3',5'-mono-phosphate, ornithine decarboxylase,and cell growth in a human colon cell line. Endocrinology,1992;131:1188.
  • 8张万岱,陈学清,宋于刚,张亚历,智发朝,周殿元.血管活性肠肽对人结肠腺癌细胞增殖的调节[J].中华消化杂志,1994,14(S1):42-45. 被引量:1
  • 9陈学清,张万岱,宋于刚,张亚历,智发朝,周殿元.血管活性肠肽对HT29结肠癌细胞系原癌基因c-myc蛋白表达的影响[J].中华消化杂志,1994,14(S1):54-56. 被引量:4

同被引文献122

引证文献14

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部